Perceptive LIFE Sciences Master FUND Ltd., Director at Astria Therapeutics, Inc. (ATXS), bought 1,816,530 shares at $11.01 ($20.0M) on 2022-12-19, disclosed to the SEC on 2022-12-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.01 | 908,265 | $10.0M | 50.0% |
| 2 | $11.01 | 908,265 | $10.0M | 50.0% |
| Total | $11.01 avg | 1,816,530 | $20.0M | 100% |
| Filing → |
| ACRV | BUY | 2024-04-15 | $20.0M | — | Filing → |
| ALDX | BUY | 2024-04-03 | $3.8M | — | Filing → |
| ALDX | SELL | 2023-10-18 | $5.0M | — | Filing → |